Open AccessLignocaine use in respiratory viruses
Author(s) -
Amjid Hammodi
Publication year - 2020
Publication title -
anaesthesia, pain and intensive care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.17
H-Index - 8
eISSN - 2220-5799
pISSN - 1607-8322
DOI - 10.35975/apic.v24i4.1332
Subject(s) - respiratory system , medicine , covid-19 , anesthesia , intensive care medicine , pain management , remedial education , psychology , disease , infectious disease (medical specialty) , mathematics education
Following the publication of the article entitled, ‘Lignocaine’s substantial role in COVID-19 management: potential remedial and therapeutic implications’, authored by Nasser Ali Malik, Amjid Hammodi and Dayanidhi Jaiswara, published in the Anaesthesia, Pain and Intensive Care; 21(1);59-63, 2020, I would like to suggest a revolutionary idea that could help control the spread of respiratory viruses from person to person, achieve potential prophylaxis against them and even could be used as a treatment for mild to moderately infected cases.